<DOC>
	<DOCNO>NCT01371526</DOCNO>
	<brief_summary>Autoimmune Addison 's disease ( AAD ) rare debilitate disease autoimmune attack progressively destroy adrenal cortex . Untreated universally fatal treated people absolutely dependent upon steroid medication lifelong , consequent excess morbidity mortality . A key feature adrenal cortex cell responsive change circulate adrenocorticotrophic hormone ( ACTH ) concentration . This study aim regenerate adrenocortical steroidogenic cell function patient establish autoimmune Addison 's disease ( AAD ) stimulate proliferation differentiation progenitor cell , adrenocortical stem cell ( ACSCs ) ( 1,2 ) . Using daily subcutaneous ACTH , administer accord two different regimen 20 week , investigate whether regeneration adrenal steroidogenic function revival ACSC activity realistic possibility .</brief_summary>
	<brief_title>Revival Stem Cells Addison 's Study</brief_title>
	<detailed_description />
	<mesh_term>Adrenal Insufficiency</mesh_term>
	<mesh_term>Cosyntropin</mesh_term>
	<criteria>Established autoimmune adrenal failure &gt; 1yr age 16 65 Significant cardiorespiratory , chronic renal nonautoimmune liver disease ; malignancy Asthma , current infectious disease , recent live vaccination , acute psychosis , peptic ulcer disease Pregnancy , breast feeding plan pregnancy within 9 month Known nonautoimmune cause adrenal failure ( haemorrhage , adrenoleukodystrophy etc . ) Known hypersensitivity allergy Synacthen</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>66 Years</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>